Placebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis

scientific article published on January 2000

Placebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/JNNP.68.1.89
P932PMC publication ID1760582
P698PubMed publication ID10601410
P5875ResearchGate publication ID12700826

P2093author name stringStangel M
Boegner F
Klatt CH
Seyfert S
Hofmeister C
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectplaceboQ269829
P304page(s)89-92
P577publication date2000-01-01
P1433published inJournal of Neurology, Neurosurgery and PsychiatryQ1599804
P1476titlePlacebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis
P478volume68

Reverse relations

cites work (P2860)
Q47835493Achievements and obstacles of remyelinating therapies in multiple sclerosis.
Q36602762Basic principles of intravenous immunoglobulin (IVIg) treatment
Q35172531Cell transplantation, myelin repair, and multiple sclerosis
Q36963208Emerging therapies for multiple sclerosis
Q35981192Escalating immunotherapy of multiple sclerosis--new aspects and practical application.
Q37989903FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination
Q51777739IVIG trials in MS. Is albumin a placebo?
Q50751771Interferon Beta-1a and intravenous immunoglobulin treatment for multiple sclerosis in Iran.
Q36602782Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis
Q37030423Intravenous polyclonal human immunoglobulins in multiple sclerosis
Q37419064Neuroprotection and neuroregeneration in multiple sclerosis
Q41173378New advances in the treatment of neurological diseases using high dose intravenous immunoglobulins
Q73384061Polyclonal IgM influence oligodendrocyte precursor cells in mixed glial cell cultures: implications for remyelination
Q73276229Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptors
Q35046922Remyelinating strategies for the treatment of multiple sclerosis
Q36113038Stem cell therapy for central nervous system demyelinating disease
Q35057210The role of intravenous immunoglobulin in the treatment of multiple sclerosis
Q80953233[Immunomodulatory effects of intravenous immunoglobulins]
Q80257893[Use of i.v. immunoglobulins in neurology. Evidence-based consensus]

Search more.